热景生物
(688068)
| 流通市值：125.16亿 | | | 总市值：125.16亿 |
| 流通股本：9270.79万 | | | 总股本：9270.79万 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 179,150,227.74 | 270,149,505.21 | 72,745,774.79 | 118,525,855.14 |
| 应收票据及应收账款 | 117,695,605.45 | 92,477,262.84 | 75,099,115.2 | 56,954,580.06 |
| 其中：应收票据 | 3,873,810.53 | 600,000 | 694,654.8 | 1,823,491.8 |
| 应收账款 | 113,821,794.92 | 91,877,262.84 | 74,404,460.4 | 55,131,088.26 |
| 应收款项融资 | - | 16,200 | - | 187,231.2 |
| 预付款项 | 30,639,387.13 | 17,888,964.11 | 24,720,251.4 | 33,676,609.66 |
| 其他应收款合计 | 3,342,837.78 | 4,121,543.9 | 11,685,430.13 | 12,174,447.41 |
| 存货 | 80,360,959.86 | 83,454,876.76 | 115,658,666.1 | 118,295,393.69 |
| 一年内到期的非流动资产 | 483,867,232.88 | 601,140,890.41 | 550,000,000 | 350,000,000 |
| 其他流动资产 | 16,186,636.87 | 21,668,802.49 | 28,570,371.31 | 28,092,880.86 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,469,794,285.16 | 1,292,423,310.23 | 1,265,944,743.09 | 1,015,904,615.48 |
| 非流动资产: | | | | |
| 长期股权投资 | 311,815,102.03 | 315,816,411.11 | 348,915,552.04 | 361,644,653.36 |
| 其他权益工具投资 | 131,615,414.24 | 131,615,414.24 | 123,580,499.79 | 123,580,499.79 |
| 其他非流动金融资产 | 180,571,589.04 | 378,605,753.43 | 419,571,191.78 | 612,627,306.72 |
| 投资性房地产 | 23,670,647.47 | 23,760,491.1 | - | - |
| 固定资产 | 1,041,084,532.23 | 1,067,938,828.35 | 1,111,181,690.57 | 1,109,893,329.58 |
| 在建工程 | 5,623,800 | 5,623,800 | 10,308,329.37 | 26,668,132.9 |
| 使用权资产 | 223,470.3 | 227,357.51 | 7,777,162.15 | 4,873,879.13 |
| 无形资产 | 51,165,611.93 | 52,124,342.73 | 52,353,277.91 | 53,296,027.14 |
| 长期待摊费用 | 24,061,397.78 | 25,549,061.03 | 20,274,217.43 | 19,659,458.54 |
| 递延所得税资产 | 27,134,354.28 | 26,636,756.11 | 29,277,656.05 | 31,631,554.77 |
| 其他非流动资产 | 5,040,639.01 | 5,540,100.16 | 21,600,977.38 | 13,054,708.65 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,802,006,558.31 | 2,033,438,315.77 | 2,144,840,554.47 | 2,356,929,550.58 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,271,800,843.47 | 3,325,861,626 | 3,410,785,297.56 | 3,372,834,166.06 |
| 流动负债: | | | | |
| 短期借款 | 50,000,000 | - | - | - |
| 应付票据及应付账款 | 139,830,804.73 | 139,653,917.15 | 82,118,937.63 | 95,521,112.4 |
| 其中：应付票据 | 9,700,000 | - | - | - |
| 应付账款 | 130,130,804.73 | 139,653,917.15 | 82,118,937.63 | 95,521,112.4 |
| 合同负债 | 13,954,620.26 | 16,703,841.11 | 16,816,089.03 | 16,277,677.31 |
| 应付职工薪酬 | 15,665,780.79 | 20,364,491.39 | 13,897,307.13 | 18,320,416.76 |
| 应交税费 | 6,285,476.48 | 5,872,667.93 | 4,940,013.34 | 2,064,422.25 |
| 其他应付款合计 | 46,127,504.45 | 52,073,992.99 | 10,070,312.76 | 12,985,347.07 |
| 应付股利 | - | - | - | 5,178,768.8 |
| 一年内到期的非流动负债 | 113,504.93 | 115,479.33 | 337,403.34 | 2,001,771.82 |
| 其他流动负债 | 1,495,861.47 | 1,109,515.82 | 351,989.03 | 461,169.13 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 273,473,553.11 | 235,893,905.72 | 128,532,052.26 | 147,631,916.74 |
| 非流动负债: | | | | |
| 租赁负债 | 118,936.07 | 121,004.94 | 8,144,936.26 | 3,341,653.69 |
| 递延收益 | 16,073,970.69 | 15,751,170.69 | 14,156,311.84 | 15,689,271.84 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 16,192,906.76 | 15,872,175.63 | 22,301,248.1 | 19,030,925.53 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 289,666,459.87 | 251,766,081.35 | 150,833,300.36 | 166,662,842.27 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 92,474,692 | 92,474,692 | 92,474,692 | 92,474,692 |
| 资本公积 | 325,128,640.39 | 321,410,553.55 | 321,374,933.59 | 437,716,263.49 |
| 减:库存股 | 205,323,172.38 | 133,893,256.85 | 92,029,848.33 | 258,510,106.23 |
| 其他综合收益 | 10,272,690.93 | 9,958,414.23 | 2,409,998.97 | 1,749,452.3 |
| 盈余公积 | 47,818,114.4 | 47,818,114.4 | 47,818,114.4 | 47,818,114.4 |
| 未分配利润 | 2,713,750,005.9 | 2,737,758,221.52 | 2,887,544,480.28 | 2,884,715,246.5 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,984,120,971.24 | 3,075,526,738.85 | 3,259,592,370.91 | 3,205,963,662.46 |
| 少数股东权益 | -1,986,587.64 | -1,431,194.2 | 359,626.29 | 207,661.33 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,982,134,383.6 | 3,074,095,544.65 | 3,259,951,997.2 | 3,206,171,323.79 |
| 负债和股东权益合计 | 3,271,800,843.47 | 3,325,861,626 | 3,410,785,297.56 | 3,372,834,166.06 |
| 公告日期 | 2025-04-30 | 2025-04-30 | 2024-10-31 | 2024-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |